GSK has been granted a patent for compounds of Formula (I) for treating mycobacterial infections like tuberculosis. The patent includes a specific compound, 4,4,4-trifluoro-1-(4-(2-(trifluoromethyl)pyridin-4-yl)piperidin-1-yl)butan-1-one. GlobalData’s report on GSK gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on GSK, Human telomerase RT biomarker was a key innovation area identified from patents. GSK's grant share as of April 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11969423B2) discloses a combination comprising a specific compound with a defined chemical structure. The compound in question is 4,4,4-trifluoro-1-(4-(2-(trifluoromethyl)pyridin-4-yl)piperidin-1-yl)butan-1-one. The patent claims cover various aspects of this combination, including its suitability for intravenous delivery and inhalable formulation.
Furthermore, the patent also specifies the inclusion of various other compounds in the combination, such as diarylquinoline (bedaquiline or TBAJ-587), oxazolidinone (linezolid, tedizolid, radezolid, sutezolid, posizolid, or TBI-223), benzothiazinone (BTZ043 or PBTZ169), azaindole (TBA-7371), and beta-lactam (meropenem, faropenem, ertapenem, tebipenem, or a beta-lactam combination). These additional compounds complement the primary compound, potentially enhancing the overall efficacy of the combination for its intended application. The patent provides a detailed description of the chemical structures and compositions involved, offering valuable insights for researchers and professionals in the pharmaceutical industry.
To know more about GlobalData’s detailed insights on GSK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
